摘要
子宫内膜异位症(endometriosis,EMs)是指具有生长功能的子宫内膜组织出现在子宫腔被覆黏膜以外的其它部位,是引起盆腔疼痛和不孕的一个常见因素。
出处
《肿瘤基础与临床》
2010年第4期365-367,共3页
journal of basic and clinical oncology
参考文献17
-
1Thomas EJ,Campbell IG.Evidence that endnmetriosis behaves in a malignant manner[J] ,Gynecol Obstet Invest,2000,50 Suppl 1:2-10.
-
2Thomas EJ,Campbell IG.Molecular genetic defects in endometriosis[J].Gynecol Obstet Invest,2000,50(Suppl 1):44-50.
-
3Obata K,Hoshiai H.Common genetic changes between endometriosis and ovarian cancer[J].Gynecol Obstet Invest,2000,50(Suppl 1):39-43.
-
4Akahane T,Sekizawa A,Purwosunu Y,et al.The role of p53 mutation in the carcinomas arising from endometriosis[J].Int J Gynecol Pathol,2007,26(3):345-351.
-
5Otsuka J,Okuda T,Sekizawa A,et al.K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma[J].Med Electron Microsc,2004,37(3):188-192.
-
6Mao L,Lee DJ,Tockman MS,et al.Microsatellite alterations as clonal markers for the detection of human cancer[J].Proc Natl Acad Sci U S A,1994,91(21):9871-9875.
-
7Amemiya S,Sekizawa A,Otsuka J,et al.Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability[J].Int J Gynaecol Obstet,2004,86(3):371-376.
-
8K(o)rner M,Burckhardt E,Mazzucchelli L.Higher frequency of chromosomal aberrations in ovarian endometriosis compared to extragonadal endometriosis:A possible link to endometrioid adenocarcinoma[J].Mod Pathol,2006,19(12):1615-1623.
-
9Artini PG,Cristello F,Monti M,et al.Vascular endothelial growth factor and its soluble receptor in ovarian pathology[J].Gynecol Endocrinol,2005,21(1):50-56.
-
10Kobayashi H.Invasive capacity of heterotopic endometrium[J].Gynecol Obstet Invest,2000,50 Suppl 1:26-32.
二级参考文献46
-
1卢美松,沈铿,郎景和.子宫内膜异位症患者雌、孕激素受体及生长因子的研究[J].中华妇产科杂志,1996,31(10):633-633. 被引量:3
-
2Heaps JM,Nieberg RK,Berek JS,et al.Malignant neoplasms arising in endometriosis[J].Obstet Gynecol,1990,75:1023-1028
-
3LaGrenade A,Silverberg SG.Ovarian tumors associate with atypical endometriosis[J].Hum Pathol,1988,19:1080-1084
-
4Bulun SE,Cheng YH,Yin P,et al.Progesterone resistance in endometriosis:link to failure to metabolize estradiol[J].Mol Cell Endocrinol,2006,248:94-103
-
5Ness RB.Endometriosis and ovarian cancer:thoughts on shared pathophysilogy[J].Am J Obstet Gynecol,2003,189:280-294
-
6Vigano P,Somigliana E,Chioda I,et al.Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis:a critical analysis[J].Hum Repr Update,2006,12:77-89
-
7Han AC,Hovenden S,Rosenblum NG,et al.Adenocarcinoma arising in extragonadal endometriosis:an immunohistochemical study[J].Cancer,1998,1163-1169
-
8Del Carmen MG,Smith Sehdev AE,Fader AN,et al.Endometriosis-associated ovarian carcinoma:differential expression of vascular endothelial growth factor and estrogen/progesterone receptors[J].Cancer,2003,98:1658-1663
-
9Sato N, Tsunoda H, Nishida M, et al. Loss of heterozygosity on 10q23. 3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary:possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary[ J ]. Cancer Res ,2000,60:7052-7056
-
10Wijnen JT, Vasen HF, Khan PM, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer[ J ]. N Engl J Med, 1998,339 : 511-518
共引文献9
-
1张登霞,杨雪萍.MMP-1/TIMP-2在子宫内膜异位症大鼠子宫内膜上的表达[J].兰州大学学报(医学版),2013,39(3):1-3.
-
2张颖,王庆一,梁艳红,陈海玲.P53、P16、PTEN、hMLH1蛋白表达与卵巢子宫内膜异位症癌变的关系[J].新医学,2010,41(6):379-382. 被引量:7
-
3潘恩云.子宫内膜异位症患者血清癌抗原125检测的临床意义[J].中国基层医药,2010,17(21):2883-2884.
-
4胡浩梅.子宫内膜异位症的恶变(综述)[J].中国城乡企业卫生,2011,26(3):64-66. 被引量:7
-
5李伟.子宫内膜异位症恶变病因的研究进展[J].吉林医学,2011,32(24):5126-5127. 被引量:2
-
6胡碧洪,黄浩.子宫内膜异位症恶变的临床研究进展[J].医学综述,2011,17(20):3090-3092. 被引量:14
-
7沈春晖,张婷婷,曹阳.子宫内膜异位症中西医病因学研究进展[J].中国中医基础医学杂志,2012,18(12):1398-1401. 被引量:12
-
8刘帅,曹保利.莪术油对大鼠子宫内膜异位症基质细胞衍生因子-1及其受体表达的影响[J].西部中医药,2018,31(3):26-29. 被引量:3
-
9刘梦娜,许天敏,张琨.铁过载与子宫内膜异位症病程进展的相关性[J].国际妇产科学杂志,2019,46(2):224-228. 被引量:7
同被引文献27
-
1王宁宁,刘斌,谭金凤,丁慧娟,洪珊珊,郑清泉,柯佩琪,黄建昭,王子莲,周灿权.广东地区子宫内膜异位症的流行趋势与特点[J].中华临床医师杂志(电子版),2010,4(7):962-965. 被引量:17
-
2王群华,凌斌,祝怀平.子宫内膜异位症恶变的研究进展[J].国外医学(妇产科学分册),2005,32(3):173-176. 被引量:3
-
3徐成康,黄建昭,冯丽萍,李智,梅卓贤,王宁宁.对子宫内膜异位症发生恶变过程的连续观察[J].中国妇幼保健,2005,20(22):2930-2931. 被引量:5
-
4徐繁华,胡兵.经皮射频消融治疗肾癌[J].中国医学影像技术,2006,22(5):779-781. 被引量:2
-
5邓顺生,钱建华,周彩云,陈晓端,吕卫国,谢幸.卵巢子宫内膜异位症恶变过程中ER、PR蛋白表达的作用[J].现代妇产科进展,2007,16(4):264-266. 被引量:4
-
6Kobayashi H.Invasive capacity of heterotopic endometrium. Gynecologic and Obstetric Investigation . 2000
-
7M. K?rner,E. Burckhardt,L. Mazzucchelli.Higher frequency of chromosomal aberrations in ovarian endometriosis compared to extragonadal endometriosis: a possible link to endometrioid adenocarcinoma. Modern Pathology . 2006
-
8Akahane T,Sekizawa A,Purwosunu Y,et al.The role of p53 mutation in the carcinomas arising from endometriosis. International Journal of Gynecological Pathology . 2007
-
9Mao L,Lee DJ,Tockman MS,et al.Microsatellite alterations as clonal markers for the detection of human cancer. Proceedings of the National Academy of Sciences of the United States of Amercia . 1994
-
10Thomas E J,Campbell I G.Molecular genetic defects in endometriosis. Gynecologic and Obstetric Investigation . 2000
引证文献4
-
1李国霞,黄风友,苏丽芳.子宫内膜异位症术后孕三烯酮治疗临床分析[J].当代医学,2011,17(19):41-42. 被引量:6
-
2李伟.子宫内膜异位症恶变病因的研究进展[J].吉林医学,2011,32(24):5126-5127. 被引量:2
-
3张仲春.米非司酮治疗子宫内膜异位症的疗效及其对卵巢储备功能的影响[J].实用临床医药杂志,2015,19(7):134-135. 被引量:28
-
4赵璟,龚颖萍,黄晓靓,陈亮,李博.超声引导下经皮射频消融治疗腹壁子宫内膜异位症的疗效观察[J].医学临床研究,2017,34(6):1145-1147. 被引量:2
二级引证文献38
-
1李景凤,孙丽宏,李馨蕊.卵巢子宫内膜异位囊肿32例误诊分析[J].吉林医学,2012,33(20):4369-4370. 被引量:2
-
2王艳波.中医治疗子宫内膜异位症52例临床体会[J].当代医学,2013,19(17):153-153.
-
3苏继颖,张虹.子宫内膜异位症恶变的临床研究[J].临床医学,2013,33(4):31-32. 被引量:1
-
4林舒,郑美娜.活血化瘀汤治疗子宫内膜异位症疗效观察[J].亚太传统医药,2014,10(6):134-135. 被引量:4
-
5潘敏.中医治疗子宫内膜异位症的临床体会[J].内蒙古中医药,2014,33(14):13-13.
-
6辛永丽.孕三烯酮治疗子宫内膜异位症疗效观察[J].中国伤残医学,2015,23(9):12-13.
-
7丁慧平.米非司酮治疗子宫内膜异位症的疗效及对卵巢储备功能的影响[J].实用妇科内分泌电子杂志,2015,2(6):34-35. 被引量:4
-
8李江宁,刁海丹.手术联合药物治疗子宫内膜异位症的临床效果研究[J].中国医药指南,2015,13(25):88-89. 被引量:2
-
9李传英,方岳军.分泌早期短程小剂量应用米非司酮治疗子宫内膜异位症中长期效果观察[J].当代医学,2016,22(15):135-136. 被引量:1
-
10刘书英,林洁.米非司酮治疗子宫内膜异位症的临床效果及对卵巢储备功能的影响[J].中外医学研究,2016,14(15):147-148. 被引量:8
-
1王倩男,李沛霖,王建玲,李洁.子宫内膜异位症恶变的临床研究进展[J].浙江医学,2017,39(7):585-588. 被引量:10
-
2代燕.发生于阔韧带的子宫内膜异位症恶变1例报告[J].当代医学,2009,15(12):47-47. 被引量:1
-
3麦玉玲,闻安民.子宫内膜异位症恶变的临床观察[J].现代医药卫生,2008,24(11):1638-1639. 被引量:1
-
4苏继颖,张虹.子宫内膜异位症恶变的临床研究[J].临床医学,2013,33(4):31-32. 被引量:1
-
5邹海琼,柴艳婷.卵巢子宫内膜样癌及其合并子宫内膜异位症的临床及病理分析[J].现代中西医结合杂志,2014,23(5):540-541. 被引量:12
-
6谢巧婷.卵巢子宫内膜样癌及其合并子宫内膜异位症的临床和病理特征分析[J].临床医药文献电子杂志,2015,2(16):3233-3233. 被引量:3
-
7冷金花,郎景和.子宫内膜异位症恶变的研究进展[J].中华妇产科杂志,2002,37(7):437-439. 被引量:76
-
8王淑兰.子宫内膜异位症恶变2例及文献复习[J].中国煤炭工业医学杂志,2006,9(10):1069-1070. 被引量:2
-
9郑秀丽,孙丽芳,徐强(编校).卵巢子宫内膜异位症恶变4例临床分析[J].中国妇幼保健,2007,22(7):973-974. 被引量:1
-
10王立宏,李亚里.子宫内膜异位症恶变的研究进展[J].现代妇产科进展,2002,11(5):369-371. 被引量:12